VELTASSA (patiromer) logo

  • ENGLISH (EN) ESPAÑOL (ES)
  • ENGLISH (EN) ESPAÑOL (ES)

Report adverse events:

Adverse events should be reported to the Vifor Pharma group.
safety@viforpharma.com

Send email
Privacy Policy

Privacy policy

Key takeaways

  • What personal data we collect when you use our website
  • What we do with your personal data How long we store your personal data and why
  • Who may have access to your personal data
  • Your rights around your personal data
  • This privacy policy explains what information we collect during your visit to our website, how we may use it, how we protect it and your rights regarding data privacy

What personal data do we collect and why?

If you send us a question or other communication to the email addresses specified as contact points, we use that information to respond to your request, If you send us an adverse event report, we record, process and forward the information in accordance with our legal obligations.

We use aggregated data collected through this website for statistical purposes to help us to understand the use of our website and how we can improve it.

We use a website analytics service to track the use of the website using cookies. This service involves the collection and use of the IP (internet protocol) address of your computer or device. For more information see our cookie policy. The IP address will only be used to identify you in exceptional circumstances, such as for legal proceedings or criminal investigations.

The legal basis for the collection and use of your personal data is our legitimate interest in having a website which allows users to send queries and other communications. In relation to personal data concerning health received via this website, such as safety information, the legal basis is public interest.

With whom do we share your personal data?

If you send us a request through this website, we may share it internally or with other companies of the Vifor Pharma Group, to collect the information required to respond to your request. You can see the location of entities of the Vifor Pharma Group at: http://www.viforpharma.com/en/about-vifor-pharma/global-presence.

We work with third-party service providers who help us to collect and process safety information and/or who provide other services such as technical support or data hosting. These service providers may have access to your personal data in order to provide the services.

We may also disclose your personal data to:

Official authorities where applicable by law (e.g. reporting adverse events for pharmacovigilance), court order or other legal proceeding, our legal and other expert advisors, distributors, license partners or other companies with whom we collaborate for the purposes specified in this privacy notice. These service providers and collaboration partners are legally bound to keep all personal information confidential and to use it only to perform the services for which we engaged them or to comply with legal pharmacovigilance obligations.

Some of the above-mentioned parties who receive your personal data may be located outside the country where you live, including in countries not regarded by the competent authorities as providing an adequate level of protection for personal data. In such cases, we ensure that appropriate safeguards are in place to protect your personal data such as EU standard contractual clauses. A copy of these clauses may be obtained from our Data Protection Officer (GroupDPO@viforpharma.com).

How long do we store your personal data?

If you send us a question or other communication to the email addresses specified as contact points, we use that information to respond to your request, If you send us an adverse event report, we record, process and forward the information in accordance with our legal obligations.

We use aggregated data collected through this website for statistical purposes to help us to understand the use of our website and how we can improve it.

We store your personal data for as long as required to fulfill the purposes outlined in this privacy policy, unless a longer or shorter retention period is required or permitted by law. By law we must store your personal data relating to safety information for at least 10 years after the medicinal product is no longer available. The legal basis for the collection and use of your personal data is our legitimate interest in having a website which allows users to send queries and other communications. In relation to personal data concerning health received via this website, such as safety information, the legal basis is public interest.

What are your rights regarding your personal data?

You are entitled at any time to access your personal data that we have. To the extent legally permissible, you can request that your data be deleted, that errors be corrected or that processing of your personal data be restricted. You can also object to our processing your personal data.

If you would like to exercise your rights, please contact us as described in the section “How to contact us” below. Please note that applicable laws may prevent us from complying with requests to delete safety information or to restrict our processing of it.

You are entitled to lodge a complaint with the supervisory authority.

Links to other sites

We may provide links to other websites that we believe are useful and meet our high standards for information accuracy and utility. However, we cannot guarantee the standards or privacy policies of the websites to which we link. We are not responsible for the content of any website which is not owned by a Vifor Pharma Group company.

Personal data of children

This website is intended for adult use only, i.e. anyone 16 years of age or older. We do not knowingly collect personal data from anyone under the age of 16 through this website. We assume that any person who provides their personal data through this website is 16 years of age or older. If you would like to contact us about personal data that your child (under 16 years old) may have provided without your consent, please see the “How to contact us” section below. If we learn that we have collected any personal data from a child under the age of 16, we will take steps to delete such information promptly.

Updates to this privacy policy

We may periodically update this privacy policy. In this case, we will post updated versions on this page. If we make significant changes to our privacy policy, we will display a prominent notice of the change on this website so that users are aware of the change. A revised privacy policy will apply only to personal data collected after its effective date (see below).

How to contact us

Please contact us if you have any questions, comments, or concerns about this privacy policy or if you wish to exercise your privacy rights to your personal data.

Vifor Fresenius Medical Care Renal Pharma Ltd.
Rechenstrasse 37
CH-9014 St. Gallen
Switzerland
(This is the “Controller” of the personal data)
+ 41 (0) 58 851 8000
GroupDPO@viforpharma.com
safety@viforpharma.com
Effective date: 02 May 2019

  • Condiciones de uso
  • Política de privacidad
  • Mapa del sitio 
  • Contacte con nosotros 
  • Configuración de cookies

Esta página web es solo un recurso informativo y no sustituye al asesoramiento médico.

Si reside en California, consulte nuestra Política de privacidad.

PP-US-VEL-02479 ©2024 Vifor Pharma, Inc. All rights reserved. All logos, trademarks, and service marks are the property of Vifor Pharma Ltd., its subsidiaries or affiliates. Site last modified 03/24.

VELTASSA es un medicamento de venta con receta que se utiliza para tratar los niveles elevados de potasio en la sangre (hiperpotasemia). Está aprobado para su uso en adultos y pacientes pediátricos de 12 años en adelante.

Información de seguridad importanteImagen eliminada. VER MENOS

¿Quién no debe tomar VELTASSA?

No tome VELTASSA si usted es alérgico a VELTASSA o a cualquiera de sus ingredientes.

¿Qué debo decirle a mi médico antes de tomar  should VELTASSA?

Antes de tomar VELTASSA, informe a su médico sobre todas sus condiciones médicas, incluyendo si usted:

  • tiene problemas para defecar, por ejemplo, si padece estreñimiento grave, un bloqueo (obstrucción) en el intestino o heces secas y duras que no salen por el recto (impactación);
  • tiene problemas intestinales después de la operación.

Conozca los medicamentos que toma. Arme una lista de ellos para mostrársela a su médico y farmacéutico cuando obtenga un nuevo medicament. Infórmele al médico sobre todos los medicamentos que toma, incluyendo los medicamentos recetados y de venta libre, las vitaminas y los suplementos a base de hierbas.

¿Cuáles son los posibles efectos secundarios de VELTASSA?

VELTASSA puede causar efectos secundarios graves, que incluyen los siguientes:

  • Empeoramiento de la función intestinal
  • Niveles bajos de magnesio en la sangre (hipomagnesemia). Pueden darse niveles bajos de magnesio en la sangre al tomar VELTASSA. Su médico comprobará los niveles de magnesio en sangre durante el tratamiento con VELTASSA y puede recetarle un suplemento de magnesio.

Los siguientes efectos secundarios de VELTASSA son los más frecuentes en pacientes adultos: estreñimiento, niveles bajos de magnesio, diarrea, náuseas, molestias en la zona del estómago (abdominales) y gases. En un estudio con pacientes pediátricos, el perfil de seguridad de VELTASSA resultó similar al de los adultos.

Infórmele a su médico si tiene algún efecto secundario que le moleste o que no desaparezca. Estos no son todos los efectos secundarios posibles de VELTASSA. Puede informar de los efectos secundarios a la FDA llamando al 1-800-FDA-1088 o en www.fda.gov/medwatch.

La información de riesgo proporcionada aquí no es exhaustiva y no reemplaza la consulta con su médico sobre su afección médica o tratamiento. Para obtener más información sobre VELTASSA, hable con su proveedor de atención médica o farmacéutico. Haga clic aquí para consultar la información de prescripción completa.

ISI

VELTASSA es un medicamento de venta con receta que se utiliza para tratar los niveles elevados de potasio en la sangre (hiperpotasemia). Está aprobado para su uso en adultos y pacientes pediátricos de 12 años en adelante.

Información de seguridad importanteImagen eliminada. VER MENOS

¿Quién no debe tomar VELTASSA?

No tome VELTASSA si usted es alérgico a VELTASSA o a cualquiera de sus ingredientes.

¿Qué debo decirle a mi médico antes de tomar  should VELTASSA?

Antes de tomar VELTASSA, informe a su médico sobre todas sus condiciones médicas, incluyendo si usted:

  • tiene problemas para defecar, por ejemplo, si padece estreñimiento grave, un bloqueo (obstrucción) en el intestino o heces secas y duras que no salen por el recto (impactación);
  • tiene problemas intestinales después de la operación.

Conozca los medicamentos que toma. Arme una lista de ellos para mostrársela a su médico y farmacéutico cuando obtenga un nuevo medicament. Infórmele al médico sobre todos los medicamentos que toma, incluyendo los medicamentos recetados y de venta libre, las vitaminas y los suplementos a base de hierbas.

¿Cuáles son los posibles efectos secundarios de VELTASSA?

VELTASSA puede causar efectos secundarios graves, que incluyen los siguientes:

  • Empeoramiento de la función intestinal
  • Niveles bajos de magnesio en la sangre (hipomagnesemia). Pueden darse niveles bajos de magnesio en la sangre al tomar VELTASSA. Su médico comprobará los niveles de magnesio en sangre durante el tratamiento con VELTASSA y puede recetarle un suplemento de magnesio.

Los siguientes efectos secundarios de VELTASSA son los más frecuentes en pacientes adultos: estreñimiento, niveles bajos de magnesio, diarrea, náuseas, molestias en la zona del estómago (abdominales) y gases. En un estudio con pacientes pediátricos, el perfil de seguridad de VELTASSA resultó similar al de los adultos.

Infórmele a su médico si tiene algún efecto secundario que le moleste o que no desaparezca. Estos no son todos los efectos secundarios posibles de VELTASSA. Puede informar de los efectos secundarios a la FDA llamando al 1-800-FDA-1088 o en www.fda.gov/medwatch.

La información de riesgo proporcionada aquí no es exhaustiva y no reemplaza la consulta con su médico sobre su afección médica o tratamiento. Para obtener más información sobre VELTASSA, hable con su proveedor de atención médica o farmacéutico. Haga clic aquí para consultar la información de prescripción completa.